Nanotechnology News

RSS

Novel RNAi and Lipid Nanoparticle Drug Demonstrates Significant Results in Treating Cancer

A study led by Dr Josep Tabernero, the Director of Clinical Research at the Vall d’Hebron Institute of Oncology (VHIO) and Head of the Medical Oncology Department at the Vall d’Hebron University Hospital, shows for the first time that ribonucleic acid interference (RNAi) is effective in the treatment of cancer patients. Harnessing these molecules to silence genes involved in the development and growth of cancer cells is an important step forward in developing a new and more targeted type of cancer therapy.

12 Feb 2013

Nanomaterials Researcher Honored with Friedrich Wilhelm Bessel Research Award

Rensselaer Polytechnic Institute Professor Ganpati Ramanath has been named a winner of the prestigious Friedrich Wilhelm Bessel Research Award by the Alexander von Humboldt Foundation in Germany.

12 Feb 2013

Artificial Atoms and Diamond Nanoparticles Used to Scan Individual Cells

Researchers from the Institute of Photonic Sciences (ICFO), in collaboration with the CSIC and Macquarie University in Australia, have developed a new technique, similar to the MRI but with a much higher resolution and sensitivity, which has the ability to scan individual cells. In an article published in Nature Nanotech, and highlighted by Nature, ICFO Prof. Romain Quidant explains how this was accomplished using artificial atoms, diamond nanoparticles doped with nitrogen impurity, to probe very weak magnetic fields such as those generated in some biological molecules.

12 Feb 2013

Nanomix Commences Evaluation of Omega-3 Cardiac Panel

Nanomix Inc., a leading nanotechnology company focused on development of next generation point of care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings, announced today that it has initiated clinical testing in the U.S. to evaluate the Omega-3 Cardiac Panel.

From Nanomix Inc 12 Feb 2013

CVD Graphene Producer Graphenea to Participate in EC Flagship Technology Project

The European Commission has just approved a 1 billion funds for the graphene industry on January 28th. Graphenea, a European company based in CIC nanoGune Nanotechnology Center, is already leading the market and takes pa...

From Graphenea 12 Feb 2013

MIT Engineers Create Genetic Circuits in Bacterial Cells

MIT engineers have created genetic circuits in bacterial cells that not only perform logic functions, but also remember the results, which are encoded in the cell’s DNA and passed on for dozens of generations.

11 Feb 2013

Researchers Work on Developing New HIV Vaccines

With the recent launch of MIT’s Institute for Medical Engineering and Science, MIT News examines research with the potential to reshape medicine and health care through new scientific knowledge, novel treatments and products, better management of medical data, and improvements in health-care delivery.

11 Feb 2013

ASU-Mayo Clinic Research Team Wins Grant to Develop Nanobodies Targeting Amyloid-â Oligomers

An external panel of venture capitalists, entrepreneurs and medical device manufacturers has awarded $100,000 grants to two joint Arizona State University-Mayo Clinic research teams that are working to apply personalized medicine to the treatment of Alzheimer’s disease and cerebral aneurysms.

11 Feb 2013

Nanoscribe Showcases 3D Printer of Micro- and Nanostructures at Photonics West

At the Photonics West, the leading international fair for photonics taking place in San Francisco (USA) this week, Nanoscribe GmbH, a spin-off of Karlsruhe Institute of Technology (KIT), presents the world's fastest 3D printer of micro- and nanostructures.

11 Feb 2013

Nanoparticle-Impregnated Tablet for Water Purification

PureMadi, a nonprofit University of Virginia organization, has invented a simple ceramic water purification tablet.

11 Feb 2013

Nano Labs to be a Sponsor and Presenter at Nanotechnologies Conference

Nano Labs Corp. is pleased to announce today that the Company will be a sponsor and presenter at the Fifteenth Meeting of the ISO/TC 229 Nanotechnologies Conference. The conference will be held from March 4 to 8, 2013 at the Hotel Fiesta Americana in Queretaro City, Mexico.

11 Feb 2013

New Strategy for Autoimmune Disease Treatment

Dana-Farber Cancer Institute scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model.

11 Feb 2013

Nanoscale Science and Technology Authority Participates at Baylor University Science Colloquium

Baylor University welcomes James Tour, Ph.D., an authority on nanoscale science and technology, as the featured lecturer in a colloquium hosted by the Office of the Vice Provost for Research and the departments of physics and chemistry. The colloquium will take place Feb. 12 and 13.

11 Feb 2013

Strategic Business Report on Global Nanocomposites Market

Research and Markets has announced the addition of the "Nanocomposites - Global Strategic Business Report" report to their offering.

11 Feb 2013

NSF Grant to Bolster UT Arlington Engineer’s Work with Microfluidic Devices

A UT Arlington mechanical engineer has been honored by the National Science Foundation with a $400,000 Early Career Development grant to support her work with microfluidic devices, which promise to improve 3D tissue and cell sample analyses.

11 Feb 2013